A meta-analysis of 25 studies found significantly lower concentrations of choline-containing compounds in the brains of people with anxiety disorders, suggesting a potential connection between brain chemistry, nutrient metabolism and mental health.
By yourNEWS Media Newsroom
People diagnosed with anxiety disorders have approximately 8% lower concentrations of choline-containing compounds in certain regions of the brain than individuals without anxiety, according to research that identifies a potentially important biochemical difference associated with several common mental health conditions.
The study, published Sept. 5, 2025, in Molecular Psychiatry, examined 25 datasets involving 370 people diagnosed with anxiety disorders and 342 healthy participants. Researchers identified consistently lower levels of choline-containing compounds in the cerebral cortex, particularly the prefrontal cortex, which plays an important role in emotional regulation, decision-making and behavior.
The findings applied to three conditions: generalized anxiety disorder, panic disorder and social anxiety disorder.
Researchers at the University of California, Davis, conducted the meta-analysis to determine whether previously reported differences in brain chemistry were consistent across anxiety disorders.
“This is the first meta-analysis to show a chemical pattern in the brain in anxiety disorders,” said Jason Smucny, an assistant professor in the Department of Psychiatry and Behavioral Sciences at UC Davis and co-author of the study.
“It suggests nutritional approaches — like appropriate choline supplementation — may help restore brain chemistry and improve outcomes for patients.”
The findings, highlighted in a UC Davis Health report published Nov. 10, 2025, offer a possible new direction for investigating the biological mechanisms underlying anxiety.
However, the research does not demonstrate that inadequate dietary choline causes anxiety or that increasing choline intake can prevent or treat anxiety disorders.
The researchers used data from studies employing proton magnetic resonance spectroscopy, a noninvasive imaging technique that measures chemical compounds within living brain tissue.
Unlike conventional MRI scans, which produce images of anatomical structures, magnetic resonance spectroscopy provides information about the chemical composition of selected brain regions.
The investigators examined several neurometabolites, including choline-containing compounds, creatine, glutamate, gamma-aminobutyric acid and N-acetylaspartate.
Choline-related compounds stood out because their concentrations were consistently lower in participants with anxiety disorders, particularly in studies using higher-quality measurement techniques.
The researchers found no comparable consistent differences among most of the other brain chemicals examined.
Richard Maddock, a psychiatrist and research professor at UC Davis who led the study, said the magnitude of the difference was noteworthy.
“An 8% lower amount doesn’t sound like that much, but in the brain it’s significant,” Maddock said.
Choline is an essential nutrient involved in several biological processes, including the production and maintenance of cell membranes, lipid metabolism and the synthesis of acetylcholine, a neurotransmitter involved in memory, learning and muscle control.
The body produces small quantities of choline, but most must come from dietary sources.
Choline also supports methylation reactions, which are involved in normal cellular metabolism and gene regulation, and plays an important role in fetal brain and nervous system development.
The researchers proposed that chronic stress and persistent physiological arousal could influence the brain’s metabolism of choline-containing compounds.
Anxiety disorders frequently involve heightened activity in biological systems responsible for responding to perceived threats.
Chemical messengers such as norepinephrine, which participate in the body’s fight-or-flight response, may affect processes involving cell membranes and methylation.
The researchers suggested that sustained arousal could increase the brain’s metabolic demand for choline-related compounds without a corresponding increase in their availability.
If confirmed, that mechanism could help explain why people with different anxiety disorders demonstrate similar chemical changes.
However, the proposed explanation remains a hypothesis rather than an established cause of anxiety.
Importantly, magnetic resonance spectroscopy measures a combination of choline-containing metabolites associated with cell membrane metabolism. It does not directly measure a person’s dietary choline intake or establish whether the individual has a nutritional deficiency.
The distinction is significant because lower brain metabolite concentrations do not necessarily indicate that a person needs additional choline from food or supplements.
Nevertheless, the findings have renewed attention on the nutrient’s role in overall health.
According to the National Institutes of Health Office of Dietary Supplements, choline is required for normal cellular function, nervous system activity and lipid transport.
The Food and Nutrition Board established adequate intake recommendations of 550 milligrams daily for adult men and 425 milligrams for adult women, with higher recommendations during pregnancy and breastfeeding.
Dietary sources include eggs, fish, meat, soybeans, potatoes, certain legumes and other plant-based foods.
Although choline is present in a variety of foods, federal dietary assessments indicate that many Americans consume less than the recommended adequate intake.
Researchers are investigating whether insufficient choline consumption contributes to particular neurological or metabolic conditions, but the relationship between dietary intake and anxiety disorders remains unclear.
Some dietary supplements contain choline compounds such as citicoline or alpha-GPC, which are marketed for cognitive and neurological support.
However, the UC Davis meta-analysis did not test these supplements, and its findings do not establish that they reduce anxiety symptoms.
Researchers also cautioned that excessive supplementation may cause adverse effects, including gastrointestinal discomfort, low blood pressure and other complications.
The NIH’s consumer guidance on choline identifies an adult tolerable upper intake level of 3,500 milligrams daily from all sources.
The study has several limitations.
Because the analysis combined previously published observational studies, it cannot determine whether altered brain chemistry contributes to anxiety or develops as a consequence of the condition.
The studies also differed in participant characteristics, brain regions examined, imaging equipment and measurement procedures.
Although researchers found stronger associations in studies with more precise measurements, additional research is needed to establish the clinical significance of the differences.
The authors concluded that lower cortical concentrations of choline-containing compounds may represent a common biological feature across several anxiety disorders.
They recommended further investigation into choline metabolism, the effects of chronic physiological arousal and whether carefully designed nutritional interventions could influence symptoms.
For now, the findings provide evidence of an association between anxiety disorders and measurable differences in brain chemistry, rather than proof that dietary choline deficiency causes anxiety.
The research nevertheless identifies a potential avenue for future studies examining how nutrition, stress physiology and brain metabolism interact in mental health.
Explainer Infographic
Comments